Study Details
A Study to Evaluate Enfortumab Vedotin versus (vs) Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Clinicaltrials.gov ID
Astellas Study ID
7465-CL-0301
EudraCT ID
2017-003344-21
Condition
Bladder Cancer
Phase
Phase 3
Age
18 Years - N/A
Sex
Female & Male
Product
enfortumab vedotin
Type
Interventional
Trial Dates
Jun 2018 - Feb 2024
Masking
None (Open Label)
Enrollment number
608
An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate Enfortumab Vedotin versus (vs) Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site AT43005
Linz, Austria
Innovative Clinical Research
Whittier, United States, 90606
Site JP81023
Fukuoka, Japan
Fox Chase Cancer Center
Philadelphia, United States, 19111
Site JP81001
Kyoto, Japan
Site NL31001
Tilburg, Netherlands
HOPE Cancer Center of East Texas
Tyler, United States, 75701
Site AU61002
Sydney, Australia
Montefiore Medical Center
Bronx, United States, 10467
Site DK45003
Aalborg, Denmark
Site ES34005
Seville, Spain
Site CA15013
Vancouver, Canada
University of California
Sacramento, United States, 95817
Providence Portland Med Center
Portland, United States, 97213
Site RU70005
Omsk, Russian Federation
Site JP81004
Hiroshima, Japan
Site DE49008
Heidelberg, Germany
Site ES34008
Valencia, Spain
Site ES34002
Badalona, Spain
Site CA15015
Calgary, Canada
Site ES34023
Barcelona, Spain
Site CA15001
Sherbrooke, Canada
Site CH41001
Chur, Switzerland
Site IT39013
Pisa, Italy
Site IT39025
Modena, Italy
Fairview Ridges Specialty Center
Burnsville, United States, 55337
Site FR33022
Paris, France
Site BE32010
Charleroi, Belgium
Site JP81013
Shinjuku-ku, Japan
Site JP81012
Koto-ku, Japan
Site JP81011
Ube, Japan
Site GB44011
Southampton, United Kingdom
Site JP81002
Yokohama, Japan
Site JP81014
Kashiwa, Japan
Site ES34019
Pamplona, Spain
Site GB44004
Wirral, United Kingdom
Site BE32011
Aalst, Belgium
Allina Health System
Minneapolis, United States, 55407
Site ES34003
Madrid, Spain
Medical College of Wisconsin
Milwaukee, United States, 53226
Site ES34017
Madrid, Spain
Site NL31003
Amsterdam, Netherlands
Site KR82012
Hwasun-gun, Republic of Korea
Site PT35105
Lisboa, Portugal
Site KR82001
Seongnam-si, Republic of Korea
Site GB44005
London, United Kingdom
Site FR33001
Brest, France
Site FR33014
Marseille, France
Site CA15014
London, Canada
UCI Chao Family Comprehensive Cancer Center
Orange, United States, 92868
Site BE32002
Roeselare, Belgium
Site GB44002
Sheffield, United Kingdom
Site JP81016
Osakasayama, Japan
Site ES34006
Madrid, Spain
Site IT39023
Lucca, Italy
Site ES34014
Córdoba, Spain
Site FR33009
Bordeaux, France
Site CA15007
Montreal, Canada
Site IT39018
Turin, Italy
Site NL31002
Amsterdam, Netherlands
Site IT39026
Moldova, Italy
Site JP81018
Morioka, Japan
Site JP81007
Sapporo, Japan
Site BE32003
Leuven, Belgium
Site FR33020
Montpellier, France
Site TW88607
Taoyuan, Taiwan, Province of China
Site JP81026
Sapporo, Japan
Site AU61001
Miranda, Australia
Site ES34012
Barcelona, Spain
Site JP81010
Hirosaki, Japan
Site DE49003
Tübingen, Germany
Toledo Clinic Cancer Center
Toledo, United States, 43623
Site IT39019
Cremona, Italy
Sidney Kimmel Center for Prostate and Urologic Cancers
New York City, United States, 10065
Site IT39014
Reggio Emilia, Italy
Site JP81005
Sendai, Japan
Site GB44008
Manchester, United Kingdom
Site PT35106
Porto, Portugal
Site AR54001
Buenos Aires, Argentina
University of Colorado
Denver, United States, 80045
Site CA15017
Kelowna, Canada
Site KR82004
Seoul, Republic of Korea
Site FR33004
Saint-Mande, France
Site ES34024
Santander, Spain
Dayton Physicians LLC
Dayton, United States, 45430
Medical Oncology Associates, PS
Spokane, United States, 99208
Site JP81008
Bunkyo-ku, Japan
Site TW88605
Kaohsiung, Taiwan, Province of China
Site GB44013
Sutton, United Kingdom
Smilow Cancer Hospital at Yale-New Haven
New Haven, United States, 06510
Providence St. Mary Regional Center
Lacey, United States, 98503
Site CA15008
Saskatoon, Canada
Site ES34011
Manresa, Spain
Site IT39010
Milan, Italy
Site RU70009
Obninsk, Russian Federation
Site AU61006
Adelaide, Australia
Roswell Park Cancer Institute
Buffalo, United States, 14263
University of Pennsylvania
Philadelphia, United States, 19104
Site CA15011
Oshawa, Canada
Site KR82003
Seoul, Republic of Korea
Site IT39004
Terni, Italy
Site JP81003
Okayama, Japan
Site JP81017
Niigata, Japan
Site BE32008
Gent, Belgium
Site AT43004
Wien, Austria
Site RU70015
Vologda, Russian Federation
Site FR33019
Toulouse, France
Site FR33021
Besancon, France
Site IT39027
Rome, Italy
Site CH41002
Bern, Switzerland
Site ES34015
Madrid, Spain
Site AU61004
St. Leonards, Australia
Site FR33005
Pierre-Bénite, France
Nebraska Cancer Specialists
Omaha, United States, 68130
Site FR33012
Paris, France
Saint Francis Hospital
Greenville, United States, 29607
Site TW88604
Taipei, Taiwan, Province of China
Site FR33002
Strasbourg, France
Site IT39008
Arezzo, Italy
Lifespan Rhode Island Hospital
Providence, United States, 02903
Site PT35102
Lisbon, Portugal
Site FR33016
Caen, France
Site AR54003
Buenos Aires, Argentina
Alaska Clinical Research Center
Anchorage, United States, 99508
Site BE32001
Gent, Belgium
Site KR82006
Daejeon, Republic of Korea
Site KR82002
Incheon, Republic of Korea
Site DE49009
Würzburg, Germany
Site CA15002
Montreal, Canada
Site BE32012
Yvoir, Belgium
Site JP81022
Osaka, Japan
Site CH41003
Winterthur, Switzerland
Site JP81006
Toyama, Japan
Site AR54002
San Miguel de Tucumán, Argentina
Site FR33015
Lyon, France
Site TW88601
Tainan, Taiwan, Province of China
Site ES34001
Barcelona, Spain
Site CA15003
Hamilton, Canada
Site TW88606
Taichung, Taiwan, Province of China
Site ES34013
Madrid, Spain
The Oncology Institute of Hope
Corona, United States, 92882
Rush University Medical Center
Chicago, United States, 60612
Site JP81021
Tokushima, Japan
Site CA15005
Toronto, Canada
Site KR82010
Seoul, Republic of Korea
Site AT43001
Salzburg, Austria
Norton Cancer Institute
Louisville, United States, 40207
Site ES34022
Santiago de Compostela, Spain
Site IT39006
San Giovanni Rotondo, Italy
Site ES34020
Oviedo, Spain
Site BE32013
Brussels, Belgium
Site FR33003
Nice, France
Site AU61003
Douglas, Australia
White Plains Hospital Center for Cancer Care – Oncology Site
White Plains, United States, 10601
Site DK45001
Herlev, Denmark
Site ES34010
Badajoz, Spain
Queens Medical Associates
Fresh Meadows, United States, 11366-1531
Site DE49010
Münster, Germany
Site ES34007
Valencia, Spain
Site KR82008
Seoul, Republic of Korea
Site TW88602
Kaohsiung, Taiwan, Province of China
UMass Memorial Medical Center
Worcester, United States, 01605
Site RU70002
Ivanovo, Russian Federation
Piedmont Cancer Institute
Atlanta, United States, 30318
Site GB44006
London, United Kingdom
W.G. Hefner VA Medical Center
Salisbury, United States, 28144
Site JP81015
Chiba, Japan
Site NL31009
Nijmegen, Netherlands
Site FR33006
Villejuif, France
Sylvester Comprehensive Cancer Center
Miami, United States, 33136
Dana-Farber Cancer Institute
Boston, United States, 02215
Benaroya Research Institute at Virginia Mason
Seattle, United States, 98101
Site JP81024
Takatsuki, Japan
Florida Hospital
Orlando, United States, 32804
Site CA15004
Quebec, Canada
Site BE32005
Hasselt, Belgium
Site JP81009
Kita-gun, Japan
Site DK45004
Copenhagen, Denmark
Site KR82005
Shin, Republic of Korea
Site DE49011
Essen, Germany
Site JP81019
Fukuoka, Japan
Ochsner Clinic Foundation
New Orleans, United States, 70121
Site BE32007
Brussels, Belgium
Site FR33018
Bordeaux, France
Site BE32009
Liège, Belgium
Site KR82007
Goyang-Si, Republic of Korea
Site CA15012
Edmonton, Canada
Site KR82009
Seoul, Republic of Korea
Site DE49013
Dresden, Germany
Long Island Jewish Medical Center
Lake Success, United States, 11042
Site JP81020
Tsukuba, Japan
The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website
© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
POWERED BY:
